EMD HEALTHCARE
LIVE

Serial Number

79455124

Owner

Merck KGaA

Filing Date

May 19, 2026

Add to watchlist:

No watchlists yet
View on USPTO

EMD HEALTHCARE Trademark

Serial Number: 79455124

EMD HEALTHCARE is a trademark filed by Merck KGaA on May 19, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Merck KGaA (9 trademarks)

Frankfurter Str. 250

Entity Type: 31

Trademark Details

Filing Date

May 19, 2026

Registration Date

Not Registered

Goods & Services

Business management and consultation services in the medical and pharmaceutical field; conducting business conferences in the medical and pharmaceutical field.

Medical apparatus, instruments and equipment; medical apparatus, instruments and equipment, namely, injection devices for pharmaceuticals; syringes for medical purposes; hypodermic syringes; needles for injections.

Pharmaceutical and medical preparations; sanitary preparations for medical purposes; dietary food and substances adapted for medical use; pharmaceutical preparations for the treatment of diseases and disorders in the fields of cardiovascular medicine, neurology, immunology, metabolic endocrinology, infertility, oncology, immuno-oncology, neuro-oncology, rare diseases; pharmaceutical preparations for the treatment of tumors, neurofibromatosis, multiple myeloma; prefilled syringes containing choriogonadotropin alfa; prefilled syringes containing follitropin alfa; prefilled syringes containing lutropin alfa; prefilled syringes containing interferon beta-1 a; prefilled syringes containing cetrorelix; small molecule therapeutic preparations for the treatment of tumors, cancer, rare diseases, neurofibromatosis, multiple myelom, and diseases in the oncological and neuro-oncological fields.

Educational services; providing of training; educational services, namely, conducting training, conferences and workshops in the medical and pharmaceutical fields; providing training about the administration of drugs; conducting educational conferences and workshops in the medical and pharmaceutical fields; providing educational information in the fields of cardiovascular medicine, neurology, immunology, metabolic endocrinology, infertility, oncology, immuno-oncology, neuro-oncology, rare diseases, tumors, neurofibromatosis, multiple myeloma.

Scientific and technological services; scientific and technological services, namely research and development in the medical and pharmaceutical field; providing online non-downloadable software for medical and pharmaceutical applications in the pharmaceutical fields of cardiovascular medicine, neurology, immunology, metabolic endocrinology, infertility, oncology, immuno-oncology, neuro-oncology, rare diseases, tumors, neurofibromatosis, multiple myeloma.

Downloadable software applications for mobile devices in the pharmaceutical fields of cardiovascular medicine, neurology, immunology, metabolic endocrinology, infertility, oncology, immuno-oncology, neuro-oncology, rare diseases, tumors, neurofibromatosis, multiple myeloma; downloadable software applications for mobile applications that enable users to access medical and pharmaceutical information in the pharmaceutical fields of cardiovascular medicine, neurology, immunology, metabolic endocrinology, infertility, oncology, immuno-oncology, neuro-oncology, rare diseases, tumors, neurofibromatosis, multiple myeloma.

Providing medical information, consultancy and advisory services; providing medical and pharmaceutical patient support services in the nature of disease management information, treatment options, and medical advice in the fields of cardiovascular medicine, neurology, immunology, metabolic endocrinology, infertility, oncology, immuno-oncology, neuro-oncology, rare diseases, tumors, neurofibromatosis, multiple myeloma; providing pharmaceutical information about drug treatments and therapeutic properties.

Filing History

APPLICATION FILING RECEIPT MAILED
Aug 10, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 10, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 30, 2026 REPR